Byhealth Co Ltd

Byhealth Co Ltd maintains a strong capital structure with a debt-to-equity ratio of 0.09, indicating a low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 2.95, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's net cash position is negative after subtracting total debt, which could pose a liquidity risk if not managed effectively.

In terms of profitability, Byhealth Co Ltd demonstrates a return on equity (ROE) of 7.04% and a return on assets (ROA) of 5.59%, which are key metrics for evaluating the company's efficiency in generating profits from its equity and assets. The company's gross profit margin is 67.67%, calculated as gross profit divided by revenue, indicating a healthy margin for its operations. The operating margin is 15.53%, reflecting the company's ability to convert revenue into operating income.

Geographically, Byhealth Co Ltd's revenue is concentrated in a single segment, with no disclosed geographic diversification. This concentration could expose the company to regional economic fluctuations and regulatory changes. The company's revenue is primarily derived from its core food processing activities, with no significant diversification into other product lines or services.

The company's growth trajectory is positive, with a current FY outlook indicating a potential increase in revenue. The next FY outlook also suggests continued growth, although the exact numeric deltas are not provided in the available data. The company's free cash flow of 360.83 million CNY indicates its ability to fund operations and potentially invest in growth opportunities.

Risk factors for Byhealth Co Ltd include medium liquidity risk and low dilution risk. The company's capital expenditure of -133.38 million CNY suggests a reduction in investment in physical assets, which could impact long-term growth. The company's dilution potential is low, with no significant changes in shares outstanding between basic and diluted shares. The company's risk assessment indicates that it is not currently facing high dilution pressure, but the negative net cash position after subtracting total debt could be a concern.

Recent events and filings do not indicate any significant changes in the company's operations or financial strategy. The company's analyst estimates suggest a positive outlook, with a mean price target of 12.82 CNY and a median price target of 13.21 CNY. The mean recommendation of 2.00 indicates a generally positive sentiment among analysts, with four buy recommendations and one hold recommendation.